Trial Profile
Phase II Study of MP-214 in Patients With Schizophrenia (Exploratory Study).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Apr 2023
Price :
$35
*
At a glance
- Drugs Cariprazine (Primary)
- Indications Schizophrenia
- Focus Adverse reactions
- Sponsors Mitsubishi Tanabe Pharma Corporation
- 11 Sep 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 Mar 2009 New trial record